Dose Selection Based on Modeling and Simulation for Rivipansel in Pediatric Patients Aged 6 to 11 Years With Sickle Cell Disease

Publisher: John Wiley & Sons Inc

E-ISSN: 2163-8306|6|12|845-854

ISSN: 2163-8306

Source: Cpt: Pharmacometrics & Systems Pharmacology, Vol.6, Iss.12, 2017-12, pp. : 845-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract